- Home
- CRVO vs NSRX Comparison
CRVO vs NSRX Comparison
Compare CRVO & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- NSRX
- Stock Information
- Founded
- CRVO 2001
- NSRX N/A
- Country
- CRVO United States
- NSRX Israel
- Employees
- CRVO N/A
- NSRX N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- NSRX Biotechnology: Pharmaceutical Preparations
- Sector
- CRVO Health Care
- NSRX Health Care
- Exchange
- CRVO Nasdaq
- NSRX Nasdaq
- Market Cap
- CRVO 67.4M
- NSRX 73.0M
- IPO Year
- CRVO N/A
- NSRX 2025
- Fundamental
- Price
- CRVO $10.51
- NSRX $7.98
- Analyst Decision
- CRVO Strong Buy
- NSRX
- Analyst Count
- CRVO 6
- NSRX 0
- Target Price
- CRVO $20.80
- NSRX N/A
- AVG Volume (30 Days)
- CRVO 119.1K
- NSRX 49.2K
- Earning Date
- CRVO 08-08-2025
- NSRX 01-01-0001
- Dividend Yield
- CRVO N/A
- NSRX N/A
- EPS Growth
- CRVO N/A
- NSRX N/A
- EPS
- CRVO N/A
- NSRX N/A
- Revenue
- CRVO $7,776,968.00
- NSRX N/A
- Revenue This Year
- CRVO N/A
- NSRX N/A
- Revenue Next Year
- CRVO N/A
- NSRX N/A
- P/E Ratio
- CRVO N/A
- NSRX N/A
- Revenue Growth
- CRVO N/A
- NSRX N/A
- 52 Week Low
- CRVO $1.80
- NSRX $7.23
- 52 Week High
- CRVO $20.63
- NSRX $9.99
- Technical
- Relative Strength Index (RSI)
- CRVO 63.06
- NSRX N/A
- Support Level
- CRVO $9.61
- NSRX N/A
- Resistance Level
- CRVO $10.89
- NSRX N/A
- Average True Range (ATR)
- CRVO 0.67
- NSRX 0.00
- MACD
- CRVO 0.04
- NSRX 0.00
- Stochastic Oscillator
- CRVO 70.28
- NSRX 0.00
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.